DoD-NCI TRICARE Feasibility Study

NCT02339025 | Completed

• 2 other identifiers: 99991506215-C-N062
• Study Type: observational
• Target: 93
• Locations: 1 country
• Sites: 1

Brief Summary

Background: \- Researchers at the National Cancer Institute and the Department of Defense are trying to learn more about what causes cancer, heart disease, and other health problems. To do this, they gather data on risk factors and biological markers. They get these data from large groups of people in long-running studies. As these groups of people age, researchers must form new groups. TRICARE is a health insurance program for uniformed service members and their families. It is a major part of the Military Health System. Researchers hope to form a new study group from TRICARE members. This study will test if TRICARE members will take part in a research study. Objectives: \- To test if TRICARE members will take part in a research study. Eligibility: \- TRICARE members aged 35 74 with military primary care providers at Walter Reed National Military Medical Center. They must not have a prior diagnosis of cancer other than non-melanoma skin cancer. Design:

• Participants will fill out a survey. It will ask about their risk factors for cancer and other chronic diseases. Their medical records will be reviewed. They will give a blood sample.
• If a larger study is formed, then participants data will be used in the larger study. They may be asked to give more samples.

Conditions

Cancer

Keywords

Cohort; Participation; Biobank

Outcome Measures

Primary Outcomes (2)

• Participation rates

  Participant rates

  End of study recruitment

• Data linkage

  Data linkage

  Before study recruitment

Secondary Outcomes (1)

• Cross-sectional biomarker study

  End of study recruitment

Study Arms (1)

Tricare Participants

From WRNMC

Eligibility Criteria

• Age: 35 Years - 74 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

All participants will be asked to access a study website, complete an on-line consent form which includes consent for access to electronic health records, complete an on-line questionnaire, and provide a blood specimen.

You may qualify if:

• Participants will be selected according to the MTF, gender, age, and race/ethnicity. Beneficiaries aged 35-74 years with military primary care providers at WRNMMC or FBCH or beneficiaries living in these catchment or service areas.

You may not qualify if:

• Beneficiaries less than 35 years of age will be excluded because cancer incidence at these ages is low and therefore it is unlikely to be feasible from a cost/information perspective to include them. Beneficiaries 75 years of age or older will be excluded because it is unlikely they will have long-term follow-up.

Sponsors & Collaborators

• National Cancer Institute (NCI): lead

Study Sites (1)

Walter Reed National Medical Center

Bethesda, Maryland, 20301, United States

Location

MeSH Terms

Conditions

Neoplasms

Study Officials

• Catherine Schairer, Ph.D.

  National Cancer Institute (NCI)

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: NIH
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 14, 2015
• First Posted: January 15, 2015
• Study Start: August 18, 2018
• Primary Completion: September 23, 2019
• Study Completion: September 23, 2019
• Last Updated: September 26, 2019

Record last verified: 2019-09

Locations

US (1)